Shareholders' Meeting 2025Assemblée Générale 2025Algemene Vergadering 202524 April 2025 Annual general shareholders’ meeting ENGFRNLSpeech Jean-Christophe Tellier, CEO Minutes AGM Convening Notice(including agenda & attendance formalities)PDFPDFPDFProxyPDFPDFPDFUCB SA/NV - Management Report Statutory accountsPDFPDFPDFUCB SA/NV -Report of the Statutory AuditorPDFPDFPDFUCB Group - 2024 Integrated Annual ReportPDFPDFPDFUCB SA/NVStatutory Annual Accounts 2024PDFPDFPDFUCB Group -2024 Remuneration ReportSee section 3.8 of theCorporate Governance Statementin the Integrated Annual ReportUCB Group -2025 Remuneration PolicyPDFPDFPDFExplanatory note on the 2025 Remuneration PolicyPDFPDFPDFOn the day of publication of the convening notice, UCB SA/NV has a total,of 194 505 658 shares outstanding, of which 189 952 928 are entitled to voteLumi Connect Online Platform - User GuidePDFPDFPDF Proposed dividendThe Board of Directors proposes to pay a gross dividend of € 1.39 per share (gross), to be approved by the annual general meeting of the shareholders.Coupon # 28Ex-dividend: 25 April 2025Record date: 28 April 2025Payment: 29 April 2025Coupon # 28 of UCB shares is payable at € 0.973 net per share after deduction of Belgian withholding tax of 30%*, via our paying agent, KBC Bank NV.* Lower withholding tax rates may be applicable depending on the specific situation of each shareholder. Integrated Annual Report 2024 2024 ONLINE REPORT Shareholders' meeting archives shareholder meeting 2024 Shareholders meeting - 2023 Shareholders meeting - 2022 Shareholders meeting - 2021 Shareholders meeting - 2020 Shareholders meeting - 2019 Shareholders meeting - 2018 Shareholders meeting - 2017 Shareholders meeting - 2016 Questions?Please send your questions to shareholders.meeting@ucb.com To be re-elected Jonathan PeacockIndependent DirectorChair of the BoardTo be re-elected in 2025End of term in 2029 BIO - J. Peacock To be elected Fiona PowrieIndependent Director To be elected in 2025End of term in 2029 BIO - F. Powrie To be elected Stef Heylen, MDDirector To be elected in 2025End of term in 2029 BIO - S. Heylen